Global split-thickness skin grafts for burns and extensive skin loss market is expected to reach USD 588,751.85 thousand by 2031 from USD 283,883.57 thousand in 2023, growing with a CAGR of 10.0% in the forecast period of 2024 to 2031.
Market Segmentation:
Global Split-Thickness Skin Grafts for Burns and Extensive Skin Loss Market, By Type (Equipments and Grafts), End User (Hospitals, Ambulatory Surgical Centers, Dermatology Clinics, and Others), Countries (U.S., Canada, Mexico, Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Turkey, Belgium, Poland, Austria, Portugal, Greece, Slovenia, Czech Republic, Iceland, Sweden, Denmark, Norway, Finland, Rest of Europe, China, Japan, India, South Korea, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031
Overview of Global Split-Thickness Skin Grafts for Burns and Extensive Skin Loss Market Dynamics:
- Driver
- Increasing incidence of burns and skin injuries
- Restraint
- High cost of treatment with skin graft procedures
- Opportunity
- Advancement in regenerative skin products fuels grafting procedure
Market Players:
The key market players operating in the global split-thickness skin grafts for burns and extensive skin loss market are listed below:
- MIMEDX GROUP Inc. (U.S.)
- Smith+ Nephew (U.K.)
- AVITA Medical Inc. (U.S.)
- B. Braun SE (Germany)
- AlloSource (U.S.)
- Zimmer Biomet (U.S.)
- Integra LifeSciences (U.S.)
- Organogenesis Inc. (U.S.)
- NOUVAG AG (Germany)
- Exsurco Medical Inc. (U.S.)
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 OBJECTIVES OF THE STUDY
- 1.2 MARKET DEFINITION
- 1.3 OVERVIEW OF GLOBAL SPLIT-THICKNESS SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS MARKET
- 1.4 MARKETS COVERED
2 MARKET SEGMENTATION
- 2.1 MARKETS COVERED
- 2.2 GEOGRAPHICAL SCOPE
- 2.3 YEARS CONSIDERED FOR THE STUDY
- 2.4 CURRENCY AND PRICING
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL
- 2.6 MULTIVARIATE MODELLING
- 2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
- 2.8 DBMR MARKET POSITION GRID
- 2.9 VENDOR SHARE ANALYSIS
- 2.10 MARKET END USER COVERAGE GRID
- 2.11 SECONDARY SOURCES
- 2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
- 4.1 STRATEGIC DECISIONS
- 4.2 TWO SEGMENTS COMPRISE THE GLOBAL SPLIT-THICKNESS SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS MARKET, BY TYPE
- 4.3 PESTEL ANALYSIS
- 4.4 PORTER'S FIVE FORCES
5 GLOBAL SPLIT-THICKNESS SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS MARKET: REGULATIONS
- 5.1 ASIA-PACIFIC REGULATORY SCENARIO FOR SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS
- 5.2 NORTH AMERICA REGULATORY SCENARIO FOR SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS
- 5.3 EUROPE REGULATORY SCENARIO FOR SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS
- 5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO FOR SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS
- 5.5 SOUTH AMERICA REGULATORY SCENARIO FOR SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS
6 MARKET OVERVIEW
- 6.1 DRIVERS
- 6.1.1 INCREASING INCIDENCE OF BURNS AND SKIN INJURIES
- 6.1.2 INCREASING ADVANCEMENTS IN SKIN GRAFTING TECHNIQUES
- 6.1.3 IMPROVED PATIENT OUTCOMES AND QUALITY OF LIFE
- 6.2 RESTRAINTS
- 6.2.1 HIGH COST OF TREATMENT WITH SKIN GRAFT PROCEDURES
- 6.2.2 STRINGENT REGULATORY REQUIREMENTS WITH SKIN GRAFT PRODUCTS
- 6.3 OPPORTUNITIES
- 6.3.1 GROWING AWARENESS AND ADOPTION ABOUT THE BENEFITS OF SPLIT-THICKNESS SKIN GRAFTS
- 6.3.2 ADVANCEMENT IN REGENERATIVE SKIN PRODUCTS FUELS GRAFTING PROCEDURE
- 6.4 CHALLENGES
- 6.4.1 LIMITED AVAILABILITY OF DONOR SITES
- 6.4.2 PRESENCE OF SKIN ALTERNATIVES OR SUBSTITUTES
7 GLOBAL SPLIT-THICKNESS SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS MARKET, BY TYPE
- 7.1 OVERVIEW
- 7.2 EQUIPMENTS
- 7.2.1 DERMATOME
- 7.2.2 MESHERS
- 7.2.3 SCALPEL
- 7.2.4 OTHERS
- 7.3 GRAFTS
- 7.3.1 INTERMEDIATE
- 7.3.2 THIN
- 7.3.3 THICK
- 7.3.4 AUTOGRAFT
- 7.3.5 ALLOGRAFT
- 7.3.6 XENOGRAFT
- 7.3.7 THIGH
- 7.3.8 LOWER LEG
- 7.3.9 TORSO
- 7.3.10 FOREARM
8 GLOBAL SPLIT-THICKNESS SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS MARKET, BY END USER
- 8.1 OVERVIEW
- 8.2 HOSPITALS
- 8.3 AMBULATORY SURGICAL CENTERS
- 8.4 DERMATOLOGY CLINICS
- 8.5 OTHERS
9 GLOBAL SPLIT-THICKNESS SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS MARKET, BY REGION
- 9.1 OVERVIEW
- 9.2 NORTH AMERICA
- 9.2.1 U.S.
- 9.2.2 CANADA
- 9.2.3 MEXICO
- 9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 U.K.
- 9.3.3 FRANCE
- 9.3.4 ITALY
- 9.3.5 BELGIUM
- 9.3.6 SPAIN
- 9.3.7 SWITZERLAND
- 9.3.8 NETHERLANDS
- 9.3.9 DENMARK
- 9.3.10 SWEDEN
- 9.3.11 NORWAY
- 9.3.12 POLAND
- 9.3.13 AUSTRIA
- 9.3.14 FINLAND
- 9.3.15 PORTUGAL
- 9.3.16 GREECE
- 9.3.17 SLOVENIA
- 9.3.18 CZECH REPUBLIC
- 9.3.19 ICELAND
- 9.3.20 REST OF EUROPE
- 9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 SOUTH KOREA
- 9.4.5 REST OF ASIA-PACIFIC
- 9.5 MIDDLE EAST AND AFRICA
- 9.5.1 SOUTH AFRICA
- 9.5.2 REST OF MIDDLE EAST AND AFRICA
- 9.6 SOUTH AMERICA
- 9.6.1 BRAZIL
- 9.6.2 REST OF SOUTH AMERICA
10 GLOBAL SPLIT-THICKNESS SKIN GRAFTS FOR BURNS AND EXTENSIVE SKIN LOSS MARKET: COMPANY LANDSCAPE
- 10.1 COMPANY SHARE ANALYSIS: GLOBAL
- 10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
- 10.3 COMPANY SHARE ANALYSIS: EUROPE
- 10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILE
- 12.1 MIMEDX GROUP, INC.
- 12.1.1 COMPANY SNAPSHOT
- 12.1.2 REVENUE ANALYSIS
- 12.1.3 COMPANY SHARE ANALYSIS
- 12.1.4 PRODUCT PORTFOLIO
- 12.1.5 RECENT DEVELOPMENT
- 12.2 SMITH+NEPHEW
- 12.2.1 COMPANY SNAPSHOT
- 12.2.2 REVENUE ANALYSIS
- 12.2.3 COMPANY SHARE ANALYSIS
- 12.2.4 PRODUCT PORTFOLIO
- 12.2.5 RECENT DEVELOPMENT
- 12.3 AVITA MEDICAL, INC.
- 12.3.1 COMPANY SNAPSHOT
- 12.3.2 REVENUE ANALYSIS
- 12.3.3 COMPANY SHARE ANALYSIS
- 12.3.4 PRODUCT PORTFOLIO
- 12.3.5 RECENT DEVELOPMENT
- 12.4 B. BRAUN SE
- 12.4.1 COMPANY SNAPSHOT
- 12.4.2 REVENUE ANALYSIS
- 12.4.3 COMPANY SHARE ANALYSIS
- 12.4.4 PRODUCT/ SERVICE PORTFOLIO
- 12.4.5 RECENT DEVELOPMENT
- 12.5 ALLOSOURCE
- 12.5.1 COMPANY SNAPSHOT
- 12.5.2 COMPANY SHARE ANALYSIS
- 12.5.3 PRODUCT PORTFOLIO
- 12.5.4 RECENT DEVELOPMENT
- 12.6 ZIMMER BIOMET.
- 12.6.1 COMPANY SNAPSHOT
- 12.6.2 REVENUE ANALYSIS
- 12.6.3 PRODUCT PORTFOLIO
- 12.6.4 RECENT DEVELOPMENT
- 12.7 INTEGRA LIFESCIENCES
- 12.7.1 COMPANY SNAPSHOT
- 12.7.2 REVENUE ANALYSIS
- 12.7.3 PRODUCT PORTFOLIO
- 12.7.4 RECENT DEVELOPMENT
- 12.8 ORGANOGENESIS INC.
- 12.8.1 COMPANY SNAPSHOT
- 12.8.2 REVENUE ANALYSIS
- 12.8.3 PRODUCT PORTFOLIO
- 12.8.4 RECENT DEVELOPMENT
- 12.9 NOUVAG AG
- 12.9.1 COMPANY SNAPSHOT
- 12.9.2 PRODUCT PORTFOLIO
- 12.9.3 RECENT DEVELOPMENT
- 12.10 EXSURCO MEDICAL, INC. (A SUBSIDIARY OF BETTCHER INDUSTRIES, INC.)
- 12.10.1 COMPANY SNAPSHOT
- 12.10.2 PRODUCT PORTFOLIO
- 12.10.3 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS